Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results

Go back to Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Fourth Quarter and Full-Year Results

Prestige Brands (PBH) Tops Q4 EPS by 8c, Revenues Beat; Offers 1Q EPS/Revenue Guidance Below Consensus

May 7, 2020 6:26 AM EDT

Prestige Brands (NYSE: PBH) reported Q4 EPS of $0.82, $0.08 better than the analyst estimate of $0.74. Revenue for the quarter came in at $251.2 million versus the consensus estimate of $239.84 million.

Revenue was $251.2 Million in Q4 and $963.0 Million in Full-Year Fiscal 2020Organic Revenue Grew 4.6% in Q4 and 1.3% in Fiscal 2020Generated Cash from Operations of $217.1 Million and Adjusted Free Cash Flow of $206.8 Million in Full-Year Fiscal 2020Net Debt Reduction of $135.2M in FY20; Proactively Increased Cash Balance to Nearly $100 Million at Fiscal Year-end

The continued focus on our three-pillar strategy and... More